Indexed in SCIE, Scopus, PubMed & PMC
pISSN 1226-4512 eISSN 2093-3827

Article

home Article View

Review Article

Korean J Physiol Pharmacol 2025; 29(2): 157-164

Published online March 1, 2025 https://doi.org/10.4196/kjpp.24.353

Copyright © Korean J Physiol Pharmacol.

Neurosteroids and neurological disorders

Gi Wan Park1,#, Hayoung Kim1,#, Seong Hyun Won1,#, Nam Hyun Kim2, and Sheu-Ran Choi2,*

1Department of Medicine, 2Department of Pharmacology, Catholic Kwandong University College of Medicine, Gangneung 25601, Korea

Correspondence to:Sheu-Ran Choi
E-mail: srchoi@cku.ac.kr

#These authors contributed equally to this work.

Author contributions: G.W.P., H.K., and S.H.W. wrote the manuscript. N.H.K. reviewed and revised the manuscript. S.R.C. supervised and coordinated the study. All authors contributed to the article and approved the submitted version.

Received: November 4, 2024; Revised: November 23, 2024; Accepted: December 1, 2024

Abstract

Neurosteroids play an important role as endogenous neuromodulators that are locally produced in the central nervous system and rapidly change the excitability of neurons and the activation of microglial cells and astrocytes. Here we review the mechanisms of synthesis, metabolism, and actions of neurosteroids in the central nervous system. Neurosteroids are able to play a variety of roles in the central nervous system under physiological conditions by binding to membrane ion channels and receptors such as gamma-aminobutyric acid type A receptors, Nmethyl- D-aspartate receptors, L- and T-type calcium channels, and sigma-1 receptors. In addition, numerous neurological disorders, including persistent neuropathic pain, multiple sclerosis, and seizures, have altered the levels of neurosteroids in the central nervous system. Thus, we review how local synthesis and metabolism of neurosteroids are modulated in the central nervous system and describe the role of neurosteroids under pathological conditions. Furthermore, we discuss whether neurosteroids may play a role as a new therapeutic for the treatment of neurological disorders.

Keywords: Nervous system diseases; Neurosteroids; Receptors, GABA; Receptors, N-methyl-D-aspartate; Sigma-1 receptor

Share this article on :

Related articles in KJPP